Key result
Aspirin fails to alter TBA-RS in TIA patients, suggesting elevation reflects altered metabolism, not platelet hyperfunction.
Why the study?
Patients with TIA were previously shown to have high plasma TBA-RS values, but the relation to platelet activability and metabolic profile was unclear.
Does aspirin affect plasma TBA-RS levels in patients with TIA?
Does aspirin affect plasma TBA-RS levels in patients with TIA?
Elevated plasma TBA-RS in TIA patients is likely an epiphenomenon of altered metabolic pathways rather than platelet hyperfunction.
No takes yet. Share an insight, caveat, or question.
Aspirin may mitigate oxidative stress in TIA via platelets; hypothesis-generating and should not yet change practice.
Violi et al. (1989) studied Transient ischemic attacks (TIA) (n=24). Aspirin vs. Controls was evaluated on Plasma values of thiobarbituric acid-reactive substances (TBA-RS). Aspirin (1 g) administration in TIA patients resulted in TBA-RS values similar to controls, suggesting elevated TBA-RS is an epiphenomenon of altered metabolism rather than platelet hyperfunction.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: